Find clinical trials for Non-Hodgkin Lymphoma in Ann Arbor, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Ann Arbor, MI, USA:
ARV-393 in patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma to determine if ARV-393 may be a po-...
Phase 1
Detroit, Michigan, United States and 16 other locations
to Standard Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracyc...
Phase 3
Detroit, Michigan, United States and 66 other locations
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Ann Arbor, Michigan, United States and 31 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Detroit, Michigan, United States and 58 other locations
This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 (docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or...
Phase 1
Maumee, Ohio, United States and 10 other locations
clinical trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two...
Phase 1, Phase 2
Detroit, Michigan, United States and 22 other locations
Carcinoma (NPC) and Non-Hodgkin Lymphoma (NHL) in Escalation and diffuse large B-cell lymphoma (DLBCL) in expans...
Phase 1, Phase 2
Ann Arbor, Michigan, United States and 17 other locations
with polatuzumab vedotin in participants with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma...
Phase 1, Phase 2
Ann Arbor, Michigan, United States and 28 other locations
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....
Phase 1
Ann Arbor, Michigan, United States and 8 other locations
This study has 2 parts.The main aim of Part 1 is to check for side effects from TAK-007 in adults with relapsed or refractory (r/r) B-cell Non...
Phase 2
Ann Arbor, Michigan, United States and 14 other locations
Clinical trials
Research sites
Resources
Legal